Skip to main content

Table 1 Patient Characteristics and LV function for HHD and healthy control groups

From: Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain

 HHD(n = 62)Controls
(n = 26)
P value
EF < 30%
(n = 22)
30%EF < 50% (n = 18)EF50
(n = 22)
Age (years)43.7 ± 13.646.3 ± 14.849.3 ± 10.344.6 ± 13.70.36
Gender20 M, 2F16 M, 2F19 M, 3F22 M, 4F0.28
BMI30.4 ± 5.925.5 ± 3.525.7 (4.5)24.6 ± 3.7< 0.05a d
EF (%)22.0 (6.6)35.8 (14.6)68.3 (9.3)61.0 (7.3)< 0.01a b e f
LVEDVI (ml/m2)149.9 (50.1)110.4 (43.2)68.3 (24.7)59.7 (23.3)< 0.01a b e f
LVESVI (ml/m2)122.1 (37.9)70.2 (19.1)21.3 (16.0)23.4 (10.0)0.000a b e f
LVSVI
(ml/m2)
32.0 (15.3)45.2 (22.6)45.5 (13.3)35.6 (14.1)< 0.05c d e
LVMI (g/m2)128.3 (40.4)115.35 (39.1)89.5 (35.6)44.7 (13.9)< 0.01a b c e
EDWT (cm)1.2 ± 0.21.2 ± 0.21.1 ± 0.20.8 ± 0.2< 0.05 a b c
  1. Abbreviations: a EF < 30% compared with Controls; b 30%EF < 50% compared with Controls; c EF50 compared with Controls; d EF < 30% compared with 30%EF < 50%; e EF < 30% compared with EF50; f 30%EF < 50% compared with EF50